versión imprimible
 
 

3rd Treg Directed Therapies Summit

Evvnt Promotion / evvnt
-
18.05.2021 - 20.05.2021  Online
Time: 09:00 - 17:30
 
Temas de la conferencia
Running digitally for 2021, the 3rd Treg Directed Therapies Summit is the industry-led meeting focused on targeting and translating Treg modifying therapies with enhanced persistence and durability safely and at scale.

Join this exclusive community online to virtually network and learn from the leading experts in pharma, biotech and academia, to discuss how to robustly modify the Treg response.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Adel Nada, CEO, GentiBio, Jeremie Mariau, CEO, ILTOO PHARMA, Jo Viney, Co-Founder, President and CSO, Pandion Therapeutics, Marc Martinez- Llordella, co-Founder and VP Biology, Quell Therapeutics and more.
 

Información e inscripción:

https://go.evvnt.com/710471-1?pid=4832
Mr. Treg Directed Therapies Summit Team
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Drug Developers (Earlybird rates and workshops available): USD 2099.0, Academic (Earlybird rates and workshops available): USD 1899.0, Service Providers (Earlybird rates and workshops available): USD 2599.0
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Österreichische Akademie der ÄrzteHelix - Forschung & Beratung WienAnästhesie in Entwicklungsländern e. V.Hilfswerk AustriaÄrztekammer für WienCharité International AcademyÖsterreichisches Rotes KreuzAMREF - African Medical and Research Foundation